Increasing Adoption of Direct Thrombin Inhibitors Boosts Bivalirudin Drug Market
The Bivalirudin Drug Market is witnessing steady growth as healthcare providers increasingly focus on effective anticoagulant therapies for patients undergoing cardiovascular procedures. Bivalirudin is a direct thrombin inhibitor primarily used to prevent blood clot formation during percutaneous coronary intervention (PCI) and other selected cardiovascular treatments. Market Overview The global...
0 Commentarii 0 Distribuiri